ArticleIn vivo (Athens, Greece)

Combination Treatment Using Pyruvate Kinase M2 Inhibitors for the Sensitization of High Density Triple-negative Breast Cancer Cells.

Ji Sun Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.